Primary Immunodeficiency Disorders Market Report 2026
Download Free Sample Buy Now
Primary Immunodeficiency Disorders Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Primary Immunodeficiency Disorders Market Report 2026

Global Outlook – By Disease (Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, Other Diseases ), By Treatment (Immunoglobulin Replacement Therapy, Antibiotic Therapy, Stem Cell And Bone Marrow Transplantation, Gene Therapy, Other Treatments), By Diagnostic Type (Genetic Testing, Blood Testing, Flow Cytometry, Other Diagnostic Types), By End-User (Hospitals, Specialty Clinics, Homecare Settings, Research Institutions) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Primary Immunodeficiency Disorders Market Overview

• Primary Immunodeficiency Disorders market size has reached to $7.3 billion in 2025

• Expected to grow to $10.01 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%

• Growth Driver: Increasing Prevalence Of Autoimmune Diseases Driving Growth Of The Market Due To Rising Cases Of Immune System Dysfunction

• Market Trend: Innovative Developments In Intravenous Immunoglobulin (IVIG) Therapy

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Primary Immunodeficiency Disorders Market?

Primary immunodeficiency disorders (PIDs) are inherited conditions that weaken or impair the immune system, increasing vulnerability to infections, autoimmune diseases, and certain cancers. Identifying and diagnosing primary immunodeficiency disorders early is crucial for timely treatment, infection prevention, and enhancing patient well-being through therapies such as immunoglobulin replacement or bone marrow transplants.

The main diseases in primary immunodeficiency disorders are antibody deficiency, cellular immunodeficiency, innate immune disorders, and others. Antibody deficiencies arise when the immune system fails to produce adequate antibodies, which are proteins responsible for identifying and neutralizing harmful pathogens. Available treatments include immunoglobulin replacement therapy, antibiotic therapy, stem cell and bone marrow transplantation, gene therapy, and others. Diagnostic methods encompass genetic testing, blood testing, flow cytometry, and others and are utilized in hospitals, specialty clinics, homecare settings, and research institutions.

Primary Immunodeficiency Disorders Market Global Report 2026 Market Report bar graph

What Is The Primary Immunodeficiency Disorders Market Size and Share 2026?

The primary immunodeficiency disorders market size has grown strongly in recent years. It will grow from $7.3 billion in 2025 to $7.79 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to improved clinical recognition of immunodeficiency disorders, expansion of diagnostic testing capabilities, rising awareness among healthcare professionals, availability of immunoglobulin therapies, growth of specialized treatment centers.

What Is The Primary Immunodeficiency Disorders Market Growth Forecast?

The primary immunodeficiency disorders market size is expected to see strong growth in the next few years. It will grow to $10.01 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing advancements in gene therapy research, rising demand for early and accurate diagnosis, expansion of precision immunology treatments, growing investment in rare disease research, increasing integration of ai in diagnostic workflows. Major trends in the forecast period include increasing adoption of genetic testing for early diagnosis, growing use of immunoglobulin replacement therapies, rising focus on personalized treatment approaches, expansion of newborn screening programs, enhanced integration of advanced diagnostic platforms.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Primary Immunodeficiency Disorders Market Segmentation

1) By Disease: Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, Other Diseases

2) By Treatment: Immunoglobulin Replacement Therapy, Antibiotic Therapy, Stem Cell And Bone Marrow Transplantation, Gene Therapy, Other Treatments

3) By Diagnostic Type: Genetic Testing, Blood Testing, Flow Cytometry, Other Diagnostic Types

4) By End-User: Hospitals, Specialty Clinics, Homecare Settings, Research Institutions

Subsegments:

1) By Antibody Deficiency: Common Variable Immune Deficiency (CVID), IgA Deficiency, IgG Subclass Deficiency, Specific Antibody Deficiency

2) By Cellular Immunodeficiency: Severe Combined Immunodeficiency (SCID), T-Cell Deficiency, DiGeorge Syndrome, Wiskott-Aldrich Syndrome

3) By Innate Immune Disorders: Chronic Granulomatous Disease (CGD), Complement Deficiencies, Toll-like Receptor Deficiencies, Chediak-Higashi Syndrome

4) By Other Diseases: Hyper IgM Syndrome, Hyper IgE Syndrome, Ataxia-Telangiectasia, Combined Immunodeficiencies With Syndromic Features

What Are The Drivers Of The Primary Immunodeficiency Disorders Market?

The growing prevalence of autoimmune diseases is expected to propel the growth of the primary immunodeficiency disorders market going forward. Autoimmune diseases occur when the immune system mistakenly attacks the body's healthy cells and tissues, treating them as foreign threats. This abnormal response leads to inflammation and damage in various organs and systems. The rise in autoimmune diseases is attributed to a complex interplay of environmental triggers, genetic predispositions, and lifestyle changes. Autoimmune diseases can cause primary immunodeficiency disorders by disrupting immune regulation and targeting immune cells, leading to weakened or dysfunctional immune responses. For instance, in February 2024, according to Arthritis Australia, an Australia-based charitable not-for-profit organisation advocating for people with arthritis and musculoskeletal conditions, by 2025, approximately 562,378 Australians are living with rheumatoid arthritis (RA), accounting for 14% of the total arthritis population. Therefore, the growing prevalence of autoimmune diseases is driving the growth of the primary immunodeficiency disorders industry.

The rising emphasis on preventive care is expected to propel the growth of the primary immunodeficiency disorders market going forward. Preventive care encompasses healthcare services and interventions aimed at preventing disease, detecting health conditions early, and promoting overall health and well-being. Preventive care is rising due to increasing awareness of early disease detection, which helps reduce severe health complications and lowers long-term healthcare costs. Primary immunodeficiency disorders highlight the importance of preventive care by demonstrating that early diagnosis and proactive management can prevent severe infections and complications, reinforcing the need for routine screenings and immunological monitoring. For instance, in March 2024, according to a report by the Government of the United Kingdom, a UK-based information website, in March 2023, the percentage of people with type 1 diabetes in England receiving 8 care processes at GP practices participating in the NDA rose to 43.8%, up from 35.2% the previous year. Therefore, the rising emphasis on preventive care is driving the growth of the primary immunodeficiency disorders industry.

Key Players In The Global Primary Immunodeficiency Disorders Market

Major companies operating in the primary immunodeficiency disorders market are Pfizer Inc, Takeda Pharmaceuticals, CSL Behring, Baxter International Inc, Grifols SA, Octapharma, Kedrion Biopharma, LFB Group, ADMA Biologics Inc, Bio Products Laboratory Ltd, Miltenyi Biotec, BD Biosciences, Cellectis SA, X4 Pharmaceuticals Inc, bluebird bio Inc, Chengdu Rongsheng Pharmaceutical Co Ltd, Sanofi SA, Roche Holding AG, Novartis AG, AbbVie Inc, AstraZeneca plc, Gilead Sciences Inc

Global Primary Immunodeficiency Disorders Market Trends and Insights

Major companies operating in the primary immunodeficiency disorders market are focusing on developing advanced therapies such as intravenous immunoglobulin therapy to enhance patient outcomes by improving immune function. Intravenous immunoglobulin (IVIG) therapy is a treatment in which immunoglobulin (antibodies) derived from donor plasma is administered directly into a patient's bloodstream via an IV. For instance, in June 2024, Grifols, a Spain-based healthcare company, received FDA approval for Yimmugo, an intravenous immunoglobulin (IVIg) therapy. This newly developed, sugar-free, ready-to-use IgG solution is derived from human blood plasma and is intended for intravenous administration. Approved in the U.S. for substitution therapy in patients with primary antibody deficiency syndromes, Yimmugo provides antibody replacement to support individuals with immune system deficiencies. It enhances Grifols’ portfolio of plasma-based treatments by offering a safer and more effective option to help protect against infections.

Need data on a specific region in this market?
Request Regional Data

Regional Outlook

North America was the largest region in the primary immunodeficiency disorders market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Primary Immunodeficiency Disorders Market?

The primary immunodeficiency disorders market consists of revenues earned by entities by providing services such as immunoglobulin therapy, rehabilitation and support programs, educational and advocacy services, and personalized treatment plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The primary immunodeficiency disorders market also includes sales of vaccines, antibiotics, antifungals, and small molecule drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Primary Immunodeficiency Disorders Market Report 2026?

The primary immunodeficiency disorders market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the primary immunodeficiency disorders industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Primary Immunodeficiency Disorders Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $7.79 billion
Revenue Forecast In 2035 $10.01 billion
Growth Rate CAGR of 6.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Disease, Treatment, Diagnostic Type, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc, Takeda Pharmaceuticals, CSL Behring, Baxter International Inc, Grifols SA, Octapharma, Kedrion Biopharma, LFB Group, ADMA Biologics Inc, Bio Products Laboratory Ltd, Miltenyi Biotec, BD Biosciences, Cellectis SA, X4 Pharmaceuticals Inc, bluebird bio Inc, Chengdu Rongsheng Pharmaceutical Co Ltd, Sanofi SA, Roche Holding AG, Novartis AG, AbbVie Inc, AstraZeneca plc, Gilead Sciences Inc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Primary Immunodeficiency Disorders Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Primary Immunodeficiency Disorders Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Primary Immunodeficiency Disorders Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Primary Immunodeficiency Disorders Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Genetic Testing For Early Diagnosis

4.2.2 Growing Use Of Immunoglobulin Replacement Therapies

4.2.3 Rising Focus On Personalized Treatment Approaches

4.2.4 Expansion Of Newborn Screening Programs

4.2.5 Enhanced Integration Of Advanced Diagnostic Platforms

5. Primary Immunodeficiency Disorders Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Homecare Settings

5.4 Research Institutions

5.5 Immunology Centers

6. Primary Immunodeficiency Disorders Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Primary Immunodeficiency Disorders Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Primary Immunodeficiency Disorders PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Primary Immunodeficiency Disorders Market Size, Comparisons And Growth Rate Analysis

7.3. Global Primary Immunodeficiency Disorders Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Primary Immunodeficiency Disorders Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Primary Immunodeficiency Disorders Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Primary Immunodeficiency Disorders Market Segmentation

9.1. Global Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, Other Diseases

9.2. Global Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoglobulin Replacement Therapy, Antibiotic Therapy, Stem Cell And Bone Marrow Transplantation, Gene Therapy, Other Treatments

9.3. Global Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genetic Testing, Blood Testing, Flow Cytometry, Other Diagnostic Types

9.4. Global Primary Immunodeficiency Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Homecare Settings, Research Institutions

9.5. Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Antibody Deficiency, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Common Variable Immune Deficiency (CVID), IgA Deficiency, IgG Subclass Deficiency, Specific Antibody Deficiency

9.6. Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Cellular Immunodeficiency, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Severe Combined Immunodeficiency (SCID), T-Cell Deficiency, DiGeorge Syndrome, Wiskott-Aldrich Syndrome

9.7. Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Innate Immune Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chronic Granulomatous Disease (CGD), Complement Deficiencies, Toll-like Receptor Deficiencies, Chediak-Higashi Syndrome

9.8. Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Other Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hyper IgM Syndrome, Hyper IgE Syndrome, Ataxia-Telangiectasia, Combined Immunodeficiencies With Syndromic Features

10. Primary Immunodeficiency Disorders Market Regional And Country Analysis

10.1. Global Primary Immunodeficiency Disorders Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Primary Immunodeficiency Disorders Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Primary Immunodeficiency Disorders Market

11.1. Asia-Pacific Primary Immunodeficiency Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Primary Immunodeficiency Disorders Market

12.1. China Primary Immunodeficiency Disorders Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Primary Immunodeficiency Disorders Market

13.1. India Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Primary Immunodeficiency Disorders Market

14.1. Japan Primary Immunodeficiency Disorders Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Primary Immunodeficiency Disorders Market

15.1. Australia Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Primary Immunodeficiency Disorders Market

16.1. Indonesia Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Primary Immunodeficiency Disorders Market

17.1. South Korea Primary Immunodeficiency Disorders Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Primary Immunodeficiency Disorders Market

18.1. Taiwan Primary Immunodeficiency Disorders Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Primary Immunodeficiency Disorders Market

19.1. South East Asia Primary Immunodeficiency Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Primary Immunodeficiency Disorders Market

20.1. Western Europe Primary Immunodeficiency Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Primary Immunodeficiency Disorders Market

21.1. UK Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Primary Immunodeficiency Disorders Market

22.1. Germany Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Primary Immunodeficiency Disorders Market

23.1. France Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Primary Immunodeficiency Disorders Market

24.1. Italy Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Primary Immunodeficiency Disorders Market

25.1. Spain Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Primary Immunodeficiency Disorders Market

26.1. Eastern Europe Primary Immunodeficiency Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Primary Immunodeficiency Disorders Market

27.1. Russia Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Primary Immunodeficiency Disorders Market

28.1. North America Primary Immunodeficiency Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Primary Immunodeficiency Disorders Market

29.1. USA Primary Immunodeficiency Disorders Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Primary Immunodeficiency Disorders Market

30.1. Canada Primary Immunodeficiency Disorders Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Primary Immunodeficiency Disorders Market

31.1. South America Primary Immunodeficiency Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Primary Immunodeficiency Disorders Market

32.1. Brazil Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Primary Immunodeficiency Disorders Market

33.1. Middle East Primary Immunodeficiency Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Primary Immunodeficiency Disorders Market

34.1. Africa Primary Immunodeficiency Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Primary Immunodeficiency Disorders Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Primary Immunodeficiency Disorders Market Regulatory and Investment Landscape

36. Primary Immunodeficiency Disorders Market Competitive Landscape And Company Profiles

36.1. Primary Immunodeficiency Disorders Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Primary Immunodeficiency Disorders Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Primary Immunodeficiency Disorders Market Company Profiles

36.3.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Takeda Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

36.3.3. CSL Behring Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Baxter International Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Grifols SA Overview, Products and Services, Strategy and Financial Analysis

37. Primary Immunodeficiency Disorders Market Other Major And Innovative Companies

Octapharma, Kedrion Biopharma, LFB Group, ADMA Biologics Inc, Bio Products Laboratory Ltd, Miltenyi Biotec, BD Biosciences, Cellectis SA, X4 Pharmaceuticals Inc, bluebird bio Inc, Chengdu Rongsheng Pharmaceutical Co Ltd, Sanofi SA, Roche Holding AG, Novartis AG, AbbVie Inc

38. Global Primary Immunodeficiency Disorders Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Primary Immunodeficiency Disorders Market

40. Primary Immunodeficiency Disorders Market High Potential Countries, Segments and Strategies

40.1 Primary Immunodeficiency Disorders Market In 2030 - Countries Offering Most New Opportunities

40.2 Primary Immunodeficiency Disorders Market In 2030 - Segments Offering Most New Opportunities

40.3 Primary Immunodeficiency Disorders Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Primary Immunodeficiency Disorders Market, Overview Of Key Products - Product Examples
  • Table 2: Global Primary Immunodeficiency Disorders Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Primary Immunodeficiency Disorders Market, Supply Chain Analysis
  • Table 4: Global Primary Immunodeficiency Disorders Market, Major Raw Material Providers
  • Table 5: Global Primary Immunodeficiency Disorders Market, Major Resource Providers
  • Table 6: Global Primary Immunodeficiency Disorders Market, Major Manufacturers (Suppliers)
  • Table 7: Global Primary Immunodeficiency Disorders Market, Major Distributors And Channel Partners
  • Table 8: Global Primary Immunodeficiency Disorders Market, Key Technologies & Future Trends
  • Table 9: Global Primary Immunodeficiency Disorders Market, Major Trends
  • Table 10: Global Primary Immunodeficiency Disorders Market, Major End Users
  • Table 11: Global Primary Immunodeficiency Disorders Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Primary Immunodeficiency Disorders Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Primary Immunodeficiency Disorders Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Primary Immunodeficiency Disorders Market - TAM, US$ Billion, 2025
  • Table 15: Global Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Primary Immunodeficiency Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Antibody Deficiency, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Cellular Immunodeficiency, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Innate Immune Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Other Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Primary Immunodeficiency Disorders Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Primary Immunodeficiency Disorders Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Primary Immunodeficiency Disorders Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Primary Immunodeficiency Disorders Market - Company Scoring Matrix
  • Table 99: Pfizer Inc Financial Performance
  • Table 100: Takeda Pharmaceuticals Financial Performance
  • Table 101: CSL Behring Financial Performance
  • Table 102: Baxter International Inc Financial Performance
  • Table 103: Grifols SA Financial Performance
  • Table 104: Global Primary Immunodeficiency Disorders Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Primary Immunodeficiency Disorders Market, Competitive Dashboard
  • Table 106: Global Primary Immunodeficiency Disorders Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Primary Immunodeficiency Disorders Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030
  • Table 108: Global, Primary Immunodeficiency Disorders Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 109: Global, Primary Immunodeficiency Disorders Market Size Gain ($ Billion), Segmentation By Diagnostic Type, 2025 – 2030

List Of Figures

    Figure 1: Global Primary Immunodeficiency Disorders Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Primary Immunodeficiency Disorders Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Primary Immunodeficiency Disorders Market, Supply Chain Analysis
  • Figure 4: Global Primary Immunodeficiency Disorders Market, Major Raw Material Providers
  • Figure 5: Global Primary Immunodeficiency Disorders Market, Major Resource Providers
  • Figure 6: Global Primary Immunodeficiency Disorders Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Primary Immunodeficiency Disorders Market, Major Distributors And Channel Partners
  • Figure 8: Global Primary Immunodeficiency Disorders Market, Key Technologies & Future Trends
  • Figure 9: Global Primary Immunodeficiency Disorders Market, Major Trends
  • Figure 10: Global Primary Immunodeficiency Disorders Market, Major End Users
  • Figure 11: Global Primary Immunodeficiency Disorders Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Primary Immunodeficiency Disorders Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Primary Immunodeficiency Disorders Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Primary Immunodeficiency Disorders Market - TAM, US$ Billion, 2025
  • Figure 15: Global Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Primary Immunodeficiency Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Antibody Deficiency, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Cellular Immunodeficiency, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Innate Immune Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Other Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Primary Immunodeficiency Disorders Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Primary Immunodeficiency Disorders Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Primary Immunodeficiency Disorders Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Primary Immunodeficiency Disorders Market - Company Scoring Matrix
  • Figure 99: Pfizer Inc Financial Performance
  • Figure 100: Takeda Pharmaceuticals Financial Performance
  • Figure 101: CSL Behring Financial Performance
  • Figure 102: Baxter International Inc Financial Performance
  • Figure 103: Grifols SA Financial Performance
  • Figure 104: Global Primary Immunodeficiency Disorders Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Primary Immunodeficiency Disorders Market, Competitive Dashboard
  • Figure 106: Global Primary Immunodeficiency Disorders Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Primary Immunodeficiency Disorders Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030
  • Figure 108: Global, Primary Immunodeficiency Disorders Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 109: Global, Primary Immunodeficiency Disorders Market Size Gain ($ Billion), Segmentation By Diagnostic Type, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Human Immunodeficiency Virus (HIV) Diagnosis Market Report 2026 - Global Outlook – By Product (Consumables, Instruments, Software, Services), By Mode (Self-Test, Lab-Based), By End User (Diagnostic Laboratories, Hospital...

Immunoassay Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Analyzers Or Instruments, Software And Services), By Specimen (Blood, Saliva, Urine, Other Specimens), By Application (Therapeutic Drug Mon...

Acne Drugs Market Report 2026 - Global Outlook – By Type (Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs), By Therapeutic Class (Retinoids, Antibiotics, Salicylic Aci, Benzoyl Peroxide, Other Therapeutics), By End ...

Immunodiagnostics Market Report 2026 - Global Outlook – By Product (Reagents And Consumables, Instruments), By Technology (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Rapid ...

Syphilis Immunoassay Diagnostics Market Report 2026 - Global Outlook – By Product (Analyzers, Reagents, Kits, Other Products), By Technology (Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA...

Walking Aids Market Report 2026 - Global Outlook – By Product Type (Crutches, Canes, Walkers, Rollators, Other Products), By Technology (Automated, Manual), By End-User (Hospitals And Clinics, Home Care Settings, Other E...

Emphysema Market Report 2026 - Global Outlook – By Type (Centrilobular, Panlobular), By Treatment (Medication, Therapy, Surgery, Other Treatments), By Diagnosis (Imaging Test, Lung Function Test, Other Diagnosis), By Com...

Immunohematology Market Report 2026 - Global Outlook – By Product (Analyzers And Systems, Reagents), By Technology (Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PC...

Frequently Asked Questions

The Primary Immunodeficiency Disorders market was valued at $7.3 billion in 2025, increased to $7.79 billion in 2026, and is projected to reach $10.01 billion by 2030.

The global Primary Immunodeficiency Disorders market is expected to grow at a CAGR of 6.5% from 2026 to 2035 to reach $10.01 billion by 2035.

Some Key Players in the Primary Immunodeficiency Disorders market Include, Pfizer Inc, Takeda Pharmaceuticals, CSL Behring, Baxter International Inc, Grifols SA, Octapharma, Kedrion Biopharma, LFB Group, ADMA Biologics Inc, Bio Products Laboratory Ltd, Miltenyi Biotec, BD Biosciences, Cellectis SA, X4 Pharmaceuticals Inc, bluebird bio Inc, Chengdu Rongsheng Pharmaceutical Co Ltd, Sanofi SA, Roche Holding AG, Novartis AG, AbbVie Inc, AstraZeneca plc, Gilead Sciences Inc .

Major trend in this market includes: Innovative Developments In Intravenous Immunoglobulin (IVIG) Therapy. For further insights on this market. request a sample here

North America was the largest region in the primary immunodeficiency disorders market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary immunodeficiency disorders market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us